shot-button
BMC Elections 2026 BMC Elections 2026
Home > Entertainment News > Hollywood News > Article > Selena Gomezs mother Mandy Teefey addresses behavioural issues denies snorting drugs at work

Selena Gomez's mother Mandy Teefey addresses behavioural issues, denies snorting drugs at work

Updated on: 05 September,2025 12:27 PM IST  |  Mumbai
mid-day online correspondent |

Selena Gomez's mother Mandy Teefey, has reacted to allegations that she would snort drugs at the workplace. The employees of her start-up Wondermind, alleged that she was often drowsy and would consume drugs and medications at the workplace

Selena Gomez's mother Mandy Teefey addresses behavioural issues, denies snorting drugs at work

Selena Gomez with mother

Listen to this article
Selena Gomez's mother Mandy Teefey addresses behavioural issues, denies snorting drugs at work
x
00:00

Selena Gomez's mom, Mandy Teefey, recently found herself in a controversy after she was accused of taking drugs in her Wondermind office. The accusations were levelled by employees of the mental health-centred media company. She has now vehemently denied the allegations. For the unversed, Wondermind is a start-up, Mandy co-founded with Selena to create mental health-related content through a website, podcasts, TV shows and movies

Mandy Teefey denies snorting drugs


Talking to The Cut, Mandy shared, "I started Wondermind because I wanted to help people with mental illness. It's unfortunate that a few disgruntled employees with an ax to grind can spread lies about me and distort the truth. Even more disappointing is that the media is willing to amplify their lies."



The 49-year-old was accused of snorting "a line of Ritalin" in her office, according to employees. Meanwhile, other employees alleged that Mandy had vitamin IV drips administered regularly by a "rotation of nurses," as another nurse would give her liquid Benadryl. 

She reportedly told employees that she needed the injections to help with "allergies and the aftermath of severe COVID and double pneumonia in late 2021." However, the employees shared that she often "spoke slowly and seemed drowsy" afterwards.

Apart from denying the overall drug allegations, Mandy also claimed that her snorting Ritalin, an ADHD medication, was "absolutely not" true.

Wondermind controversy

In the summer of 2023, Wndermind employees claimed that Selena often stepped in to pay employees and financially support them as the nonprofit struggled to secure funding. When concerns regarding Wondermind not paying employees came to light in May, the company informed Forbes that it had "rectified" the situation.

A spokesperson reportedly said, "Like many startups, Wondermind has been working through its own set of growing pains. In the coming days, we will be transitioning into a new chapter for Wondermind and continuing our important work in mental fitness that helps hundreds of thousands of people." 

In 2022, Selena had shared a press release announcing the company, saying, "Every person has their own mental health journey. If we ignore them, glamorise them or hide them from the world, it doesn't change that the journey is very real." She added, "Wondermind is extending a larger mental health conversation that began for so many during this pandemic."

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Did you find this article helpful?

Yes
No

Help us improve further by providing more detailed feedback and stand a chance to win a 3-month e-paper subscription! Click Here

Note: Winners will be selected via a lucky draw.

Help us improve further by providing more detailed feedback and stand a chance to win a 3-month e-paper subscription! Click Here

Note: Winners will be selected via a lucky draw.

selena gomez Controversial Hollywood hollywood news Entertainment News

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK